Mobidiag Receives Final €4M Tranche of €15M Financing Project

Feb

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.

Feb

Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.

Menu

Mobidiag Receives Final €4M Tranche of €15M Financing Project

To read the full story....

Breaking News

Rhinostics Licenses Procter & Gamble Nasal Swab for COVID-19 Testing

FIND, Unitaid Ink First Agreement to Enable COVID-19 Antigen Tests at $2.50 Apiece

Oppenheimer Initiates Coverage of DermTech With Outperform Rating

Invitae Prices $400M Common Stock Offering

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

In Brief This Week: Myriad Genetics, Precipio, LumiraDx, Guardant Health, and More

Featured White Papers

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

What's Popular?

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test

CDC Study Finds Abbott BinaxNow SARS-CoV-2 Antigen Test Less Sensitive Than PCR, But Still Useful

OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay

Lucira Health Files for $115M IPO

Sponsorships